These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1915817)

  • 1. [The angioprotector and hypolipemic activity of leukomizin in experimental atherosclerosis].
    Kirmukov AG; Aĭzikov MI; Rasulova SA; Sidiakin GP; Sham'ianov ID; Malikov VM
    Farmakol Toksikol; 1991; 54(3):35-7. PubMed ID: 1915817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anti-atherosclerotic action of mildronate in experiment].
    Okunevich IV; Ryzhenkov VE
    Patol Fiziol Eksp Ter; 2002; (2):24-7. PubMed ID: 12152427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The hypolipidemic and antiatherosclerotic action of absorbable and nonabsorbable substances in the intestines].
    Ryzhenkov VE; Chistiakova AM; Okunevich IV
    Patol Fiziol Eksp Ter; 1989; (5):16-9. PubMed ID: 2616207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experimental hypolipidemic and antiatherosclerotic activity of bisanions].
    Ryzhenkov VE; Khromov-Borisov NV; Mosina IV; Indenbom ML
    Farmakol Toksikol; 1979; 42(6):632-5. PubMed ID: 499472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical effects of moderate diet and clofibrate on swine atherosclerosis.
    Augustyn JM; Fritz KE; Daoud AD; Jarmolych H; Lee KT
    Arch Pathol Lab Med; 1978 Jun; 102(6):294-7. PubMed ID: 580721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of ximedon on cholesterol metabolism and experimental atherosclerosis in rabbits].
    Dautova GS; Kosykh VA; Repin VS; Kamburg RA; Ibragimov OB; Popova LG; Valeeva IKh
    Eksp Klin Farmakol; 1995; 58(1):25-9. PubMed ID: 7787689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The comparative characteristics of the antiatherogenic effect of xymedon and parmidine].
    Kamburg RA; Ibragimov OB; Kondrat'eva MB; Valeeva IKh; Shamsutdinov NSh
    Biull Eksp Biol Med; 1993 Aug; 116(8):205-8. PubMed ID: 8274706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The antiatherosclerotic effects of a polysaccharide from raw animal stock].
    Rasulov MM; Velikaia MV; Zabozlaev AG; Kuznetsov IG; Voronkov MG
    Biull Eksp Biol Med; 1993 Nov; 116(11):460-2. PubMed ID: 7508765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial suppression by pyridinolcarbamate of growth and necrosis of atherosclerotic lesions in swine subjected to an atherogenic regimen that produces advanced lesions.
    Lee WM; Lee KT; Thomas WA
    Exp Mol Pathol; 1979 Feb; 30(1):85-93. PubMed ID: 421864
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypolipidemic effect of a new aryloxy compound, S-8527, in experimental animals.
    Suzuki K; Aono S; Nakatani H
    Jpn J Pharmacol; 1974 Jun; 24(3):407-14. PubMed ID: 4449146
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hypolipidemic, hypocholesterolemic and antisclerotic action of the rotenoid glycoside amorphin].
    Kurmukov AG; Aĭzikov MI; Rasulova SA; Makhmudov OKh
    Farmakol Toksikol; 1986; 49(6):54-7. PubMed ID: 3817147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current trends in the therapy of arteriosclerotic disease].
    Toscano S
    G Clin Med; 1974 Jan; 55(1):27-39. PubMed ID: 4369524
    [No Abstract]   [Full Text] [Related]  

  • 13. Hypolipemic activity of benzoyl ester of polyoxypropylene-polyoxyethylene block copolymer (BEP) in rabbits.
    Kapuscinska B; Bochenek WJ; Pikiewicz K
    Atherosclerosis; 1982 Nov; 45(2):235-9. PubMed ID: 7159496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hypolipidemic properties of triterpenoids].
    Vasilenko IuK; Lisevitskaia LI; Frolova LM; Parfent'eva EP; Skul'te IV
    Farmakol Toksikol; 1982; 45(5):66-70. PubMed ID: 7140959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiatherogenic effect of pyridinolcarbamate (prodectin). Experimental study.
    Orbetzova V; Jurukova Z; Orbetzova M
    Artery; 1980; 8(6):560-9. PubMed ID: 7259535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of metformin on lipid-induced atherosclerosis.
    Agid R; Marquié G
    Adv Metab Disord; 1973; 2():Suppl 2:575-86. PubMed ID: 4720389
    [No Abstract]   [Full Text] [Related]  

  • 17. Antihyperlipidemic activity of sesquiterpene lactones and related compounds.
    Hall IH; Lee KH; Starnes CO; Muraoka O; Sumida Y; Waddell TG
    J Pharm Sci; 1980 Jun; 69(6):694-7. PubMed ID: 7205585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The use of ethonium as an angioprotector in treating experimental atherosclerosis].
    Pertsovskiĭ AI; Kononova NS; Chukreeva LN
    Vrach Delo; 1990 Apr; (4):103-4. PubMed ID: 2275140
    [No Abstract]   [Full Text] [Related]  

  • 19. [The effect of clofibrate (Miscleron) and pyridinol carbamate (Prodectin) on immunologic factors in experimental arteriosclerosis].
    Szondy E; Horváth M; Füst G; Fehér J; Link E; Gerö S
    Orv Hetil; 1979 Jun; 120(23):1391-2. PubMed ID: 492681
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experimental study of the anti-inflammatory action of pyridinolcarbamate].
    Shvarts GIa; Liberman SS; Mashkovskiĭ MD; Berliand EA
    Farmakol Toksikol; 1975; 38(4):434-6. PubMed ID: 1213130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.